Multiple Sclerosis (MS): Difference between revisions

No edit summary
No edit summary
Line 2: Line 2:


'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}   </div>  
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}   </div>  
<ref name="Pubmed">U.S National Library of Medicine. PubMed Health. Multiple Sclerosis. September 25, 2013. Available at:http: //www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001747/,Accessed March 19, 2014.</ref>


== Definition/Description  ==
== Definition/Description  ==


Multiple Sclerosis (MS) is an autoimmune disorder in which the body's immune cells attack the central nervous system, affecting the brain, spinal cord and optic nerve (pubmed). MS is characterized by inflammation, demyelination and gliosis. An inflammatory response occurs when the body's immune cells attack the CNS, which leads to an increase in pressure and therefore disrupting the nerve conductivity. Demyelination is a process where a nerves protective covering, known as myelin, is damaged due to the autoimmune response leading to decreased nerve conduction velocity and early fatigue of the nerve. Gliosis occurs when demyelinated areas become fibrotic, which causes proliferation of neuroglial tissue in the CNS and leads to scarring of the tissue (O'Sullivan).
Multiple Sclerosis (MS) is an autoimmune disorder in which the body's immune cells attack the central nervous system, affecting the brain, spinal cord and optic nerve<references />. MS is characterized by inflammation, demyelination and gliosis. An inflammatory response occurs when the body's immune cells attack the CNS, which leads to an increase in pressure and therefore disrupting the nerve conductivity. Demyelination is a process where a nerves protective covering, known as myelin, is damaged due to the autoimmune response leading to decreased nerve conduction velocity and early fatigue of the nerve. Gliosis occurs when demyelinated areas become fibrotic, which causes proliferation of neuroglial tissue in the CNS and leads to scarring of the tissue (O'Sullivan).


== Prevalence  ==
== Prevalence  ==

Revision as of 03:48, 20 March 2014

Original Editors -Sarah Demarest & Beth Niehbur from Bellarmine University's Pathophysiology of Complex Patient Problems project.

Top Contributors - Elizabeth Niebuhr, Vidya Acharya, Sarah Demarest, Nikhil Benhur Abburi, Laura Ritchie, Garima Gedamkar, Kim Jackson, Lucinda hampton, Bram Van Laer, Admin, Eta Frida, Rachael Lowe, Magdalena Hytros, Naomi O'Reilly, WikiSysop, Wendy Walker, Evan Thomas, Memoona Awan, Venus Pagare, Sheik Abdul Khadir, 127.0.0.1, Elaine Lonnemann, Jess Bell, Rishika Babburu, Elien Lebuf, Tarina van der Stockt, Rucha Gadgil and Jaroslaw Pospiech   </div>

[1]

Definition/Description[edit | edit source]

Multiple Sclerosis (MS) is an autoimmune disorder in which the body's immune cells attack the central nervous system, affecting the brain, spinal cord and optic nerve

  1. U.S National Library of Medicine. PubMed Health. Multiple Sclerosis. September 25, 2013. Available at:http: //www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001747/,Accessed March 19, 2014.

. MS is characterized by inflammation, demyelination and gliosis. An inflammatory response occurs when the body's immune cells attack the CNS, which leads to an increase in pressure and therefore disrupting the nerve conductivity. Demyelination is a process where a nerves protective covering, known as myelin, is damaged due to the autoimmune response leading to decreased nerve conduction velocity and early fatigue of the nerve. Gliosis occurs when demyelinated areas become fibrotic, which causes proliferation of neuroglial tissue in the CNS and leads to scarring of the tissue (O'Sullivan).

Prevalence[edit | edit source]

add text here

Characteristics/Clinical Presentation[edit | edit source]

add text here

Associated Co-morbidities[edit | edit source]

add text here

Medications[edit | edit source]

add text here

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

add text here

Etiology/Causes[edit | edit source]

add text here

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)[edit | edit source]

add text here

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Alternative/Holistic Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

add appropriate resources here

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Extension:RSS -- Error: Not a valid URL: addfeedhere|charset=UTF-8|short|max=10

References[edit | edit source]

see adding references tutorial.